InsiderTrades

Form 4 for OM Outset Medical, Inc.

Accepted 2022-12-01 00:00:00 ET · period of report 2022-11-30 · accession 0001484612-22-000081 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-01 2022-11-30 OM Brottem John L. GC M - OptEx $9.48 +12.8K 43.8K +41% +$121.0K
D 2022-12-01 2022-11-30 OM Brottem John L. GC S - Sale+OE $20.34 -12.8K 31.0K -29% -$259.6K
D 2022-12-01 2022-11-30 OM Brottem John L. GC M - OptEx $0.00 -12.8K 25.5K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-30 M A 12,761 $9.48 43,805 D — —
2 Common Common Stock 2022-11-30 S D 12,761 $20.34 31,044 D — — (F1) The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $20.29 to $20.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.
3 Derivative Non-Qualified Stock Option (right to buy) 2022-11-30 M D 12,761 $0.00 25,462 D $9.48 · — to 2030-05-26 12,761 Common Stock (F2) This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.